Nathan Rice
Stock Analyst at Piper Sandler
(2.74)
# 1,970
Out of 4,947 analysts
56
Total ratings
42.86%
Success rate
7.92%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBIN Merchants Bancorp | Maintains: Overweight | $42 → $41 | $33.07 | +23.98% | 8 | Jul 30, 2025 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $47 → $49 | $38.86 | +26.09% | 4 | Jul 28, 2025 | |
| BFC Bank First | Maintains: Neutral | $115 → $137 | $123.82 | +10.64% | 8 | Jul 21, 2025 | |
| BY Byline Bancorp | Reiterates: Overweight | $34 | $27.50 | +23.64% | 8 | Oct 29, 2024 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $66.73 | +10.89% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $131.44 | -36.09% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $142.88 | +37.88% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $18.00 | -50.00% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $653.95 | -33.48% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $290.35 | -19.75% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $26.93 | +208.21% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $17.79 | -15.68% | 1 | Dec 19, 2019 |
Merchants Bancorp
Jul 30, 2025
Maintains: Overweight
Price Target: $42 → $41
Current: $33.07
Upside: +23.98%
First Mid Bancshares
Jul 28, 2025
Maintains: Overweight
Price Target: $47 → $49
Current: $38.86
Upside: +26.09%
Bank First
Jul 21, 2025
Maintains: Neutral
Price Target: $115 → $137
Current: $123.82
Upside: +10.64%
Byline Bancorp
Oct 29, 2024
Reiterates: Overweight
Price Target: $34
Current: $27.50
Upside: +23.64%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $66.73
Upside: +10.89%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $131.44
Upside: -36.09%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $142.88
Upside: +37.88%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $18.00
Upside: -50.00%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $653.95
Upside: -33.48%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $290.35
Upside: -19.75%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $26.93
Upside: +208.21%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $17.79
Upside: -15.68%